XTalks

DECEMBER 20, 2023

In 2024, pharma companies and emerging biotechs will improve candidate safety profiles and reduce off-target effects by exploiting predictive intelligence unlocked by AI,” she predicts. CRISPR Gene Editing Therapeutics CRISPR/Cas-9 technology makes lists like this almost every year, and for good reason.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

pharmaphorum

JANUARY 14, 2021

Healthcare technology firm Seqster has introduced a new version of its service that aims to help pharma companies work with patients’ data while on virtual clinical trials. service will allow secure access to real-world data from electronic health records (EHRs), DNA analysis and fitness wearables. The new Seqster 7.1

Trials 52

Trials Clinical Trials Clinical Trials Pharma Companies 52

pharmaphorum

JANUARY 29, 2021

‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because these technologies involve literally cutting DNA at a specific point in the genome. The company’s primary technology is its zinc finger (ZF) platform.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

JULY 5, 2021

The new deal will assists the company’s focus “on advancing and innovating Parexel to meet our customers’ needs across the evolving clinical development landscape,” he added. ” The deal is subject to the usual conditions, including receipt of various approvals from regulators around the world.

Clinical Trials 64

Clinical Trials Clinical Trials Trials Regulation 64

pharmaphorum

DECEMBER 21, 2020

Compared with many of the established names in pharma these companies are young upstarts but they have managed to achieve what other big names in the industry have failed to do and harness the power of mRNA to make medicine. He told pharmaphorum: “They are very good doctors, scientists and entrepreneurs.

Vaccine 111

Vaccine Vaccination Doctor Doctors 111

pharmaphorum

DECEMBER 9, 2022

The PharmaStars accelerator was set up last year to help bridge the gap between digital health start-ups and potential pharma partners, which can be instrumental in making sure their technologies meet their potential – and help them to navigate the challenges of developing them in the highly regulated healthcare environment.

Life Science 52

Life Science DNA Genome Genomics 52

pharmaphorum

SEPTEMBER 8, 2022

However, there is a difference between the two: the toxic payloads of ADCs need to be absorbed into cancer cells, whereas radiopharmaceuticals can still do damage even when only bound to the cancer, and are particularly sensitive to radiation-induced DNA damage. Investment is flowing.

Manufacturing 105

Manufacturing Development Antibody Drugs 105

XTalks

DECEMBER 27, 2022

The pharma company will expand its manufacturing capacity for commercial scale vector production for oncology treatment. Then, the cells translate the DNA sequence of the gene and secrete high amounts of the protein interferon alfa-2b. This protein is naturally occurring in the human body and the body uses it to fight cancer.

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

Delveinsight

JULY 29, 2020

British-Swedish pharma company AstraZeneca in collaboration with Jenner Institute (Oxford University) is working on Covid-19 vaccine ChAdOx1 nCoV-19 /AZD1222. Based in Ahmedabad, Zydus Cadila is one of the top most pharma companies in the Indian pharmaceutical industry. Zydus Cadila ( ZyCoV-D ).

Vaccine 62

Vaccine Vaccination Clinical Trials Clinical Trials 62

The Pharma Data

OCTOBER 14, 2020

Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52

XTalks

DECEMBER 22, 2021

The gene-editing tool CRISPR edits DNA using specialized strands of guide RNA and endogenous cellular mechanisms of RNA interference. To develop these novel RNA-based therapeutics, we saw a number of big pharma companies team up with smaller biotechs focused on developing RNA-based therapeutics.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Pharma Marketing Network

NOVEMBER 4, 2020

RJ (PMN): One of the things I’m thinking about as you’re describing the kind of multiple permutations that could evolve and I’ve seen this in some of the examples you say to be for about like AI creating its own musical composers which have gotten really quite good and and fascinating. RJ (PMN): Fascinating stuff.

Branding 52

Branding Marketing Regulation Production 52

XTalks

OCTOBER 1, 2020

At Nurix, Dr. Hansen focuses on establishing the company’s DNA-encoded library technology platform for small molecule identification and leading the discovery organization. However, within industry organizations such as large pharma companies, funding tends to differ at each stage of research and development.

Scientist 52

Scientist In-Vitro Research Life Science 52

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. Stimulates DNA and RNA synthesis. Why do doctors prescribe drugs which are so powerful they require a second set of medication just to deal with the side effects! It’s all about the bottom line, at any cost.

Production 52

Production Pharmacy Doctor Doctors 52

Pharmaceutical Technology

MAY 26, 2023

Enzymatic DNA production company Touchlight have augmented its DNA production capabilities with a newly announced expansion to its London facilities. Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines.

DNA 130

DNA Manufacturing Gene Gene Therapy 130

Roots Analysis

AUGUST 13, 2024

The mRNA encoding instructions for protein synthesis are transferred from a strand of DNA to the ribosomes, where these instructions are translated and processed into functional proteins. Additionally, the companies are evaluating various mRNA delivery technologies in order to ensure efficient and safe delivery of mRNA-based drugs.

Vaccine 40

Vaccine Vaccination Manufacturing Protein 40

The Pharma Data

DECEMBER 16, 2020

the company is exploring other ways to combat COVID-19. AstraZeneca is partnering with INOVIO and multiple universities to advance INOVIO’s innovative DNA-encoded monoclonal antibody (dMAb) technology. and will leverage a major COVID-19 vaccine partnership the company struck with the U.K. The study will be conducted in the U.K.

Vaccine 52

Vaccine Vaccination DNA Antibody 52